Pharmacologic defibrillation
暂无分享,去创建一个
Wanchun Tang | M. Weil | S. Wann | T. Pellis | Shijie Sun
[1] M. Weil,et al. K(ATP) channel activation reduces the severity of postresuscitation myocardial dysfunction. , 2000, American journal of physiology. Heart and circulatory physiology.
[2] Y. Sato,et al. High-energy defibrillation increases the severity of postresuscitation myocardial dysfunction. , 1997, Circulation.
[3] R. Damiano,et al. Improved Nonthoracotomy Defibrillation Based on Ventricular Fibrillation Waveform Characteristics , 1996, Pacing and clinical electrophysiology : PACE.
[4] R. Berg,et al. Myocardial dysfunction after resuscitation from cardiac arrest: an example of global myocardial stunning. , 1996, Journal of the American College of Cardiology.
[5] M. Weil,et al. Myocardial dysfunction after successful resuscitation from cardiac arrest. , 1996, Critical care medicine.
[6] P. Anderson,et al. 23Na and 31P nuclear magnetic resonance studies of ischemia-induced ventricular fibrillation. Alterations of intracellular Na+ and cellular energy. , 1995, Circulation research.
[7] W. Linz,et al. Protective effects of HOE642, a selective sodium-hydrogen exchange subtype 1 inhibitor, on cardiac ischaemia and reperfusion. , 1995, Cardiovascular research.
[8] K. Ytrehus,et al. Inhibition of sodium-hydrogen exchange reduces infarct size in the isolated rat heart--a protective additive to ischaemic preconditioning. , 1995, Cardiovascular research.
[9] M. Valentinuzzi,et al. Heart Weight Affects Spontaneous Defibrillation But Not Ventricular Fibrillation Threshold , 1994, Pacing and clinical electrophysiology : PACE.
[10] R. Damiano,et al. Integration of absolute ventricular fibrillation voltage correlates with successful defibrillation , 1994, IEEE Transactions on Biomedical Engineering.
[11] M. Weil,et al. Progressive myocardial dysfunction after cardiac resuscitation , 1993, Critical care medicine.
[12] W. Linz,et al. Hoe 694, a new Na+/H+ exchange inhibitor and its effects in cardiac ischaemia , 1993, British journal of pharmacology.
[13] P. Safar,et al. Cardiovascular function and neurologic outcome after cardiac arrest in dogs. The cardiovascular post-resuscitation syndrome. , 1993, Resuscitation.
[14] M. Karmazyn,et al. Protective effects of amiloride on the ischemic reperfused rat heart. Relation to mitochondrial function. , 1992, European journal of pharmacology.
[15] R. Califf,et al. Thrombolytic therapy in patients requiring cardiopulmonary resuscitation. , 1991, The American journal of cardiology.
[16] G A Ewy,et al. Depletion of myocardial adenosine triphosphate during prolonged untreated ventricular fibrillation: effect on defibrillation success. , 1990, Resuscitation.
[17] E. Lakatta,et al. Role of calcium and the calcium channel in the initiation and maintenance of ventricular fibrillation. , 1990, Circulation research.
[18] S. Kaul,et al. Reversible Myocardial Depression in Survivors of Cardiac Arrest , 1990, Pacing and clinical electrophysiology : PACE.
[19] L. Opie. Reperfusion injury and its pharmacologic modification. , 1989, Circulation.
[20] M. Tani,et al. Role of Intracellular Na+ in Ca2+ Overload and Depressed Recovery of Ventricular Function of Reperfused Ischemic Rat Hearts Possible Involvement of H+-Na+ and Na+-Ca2+ Exchange , 1989, Circulation research.
[21] W. Nayler,et al. Calcium-mediated damage during post-ischaemic reperfusion. , 1988, Journal of molecular and cellular cardiology.
[22] M. Lazdunski,et al. The sodium/hydrogen exchange system in cardiac cells: its biochemical and pharmacological properties and its role in regulating internal concentrations of sodium and internal pH. , 1985, Journal of molecular and cellular cardiology.
[23] E. Braunwald,et al. The Stunned Myocardium: Prolonged, Postischemic Ventricular Dysfunction , 1982, Circulation.
[24] E. Nagel,et al. Prehospital ventricular defibrillation. Prognosis and follow-up course. , 1974, The New England journal of medicine.